Stock Events

Stock Events

NEUROTECH INTL LTD ORD 

$0.001000
2
-$0.00-0% Thursday 20:00

Statistics

Day High
-
Day Low
-
52W High
0.001
52W Low
0.001
Volume
-
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

2SepExpected
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
-0.45
-0.3
-0.15
-0
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-13.65MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Anavex Life Sciences
AVXL
Mkt Cap277.16M
Anavex Life Sciences Corp. focuses on developing treatments for neurological disorders, similar to NTI's focus on neurology and brain health.
Axon Enterprise
AXON
Mkt Cap48.8B
Axon Neuroscience SE engages in the development of therapeutics for neurodegenerative diseases, directly competing in NTI's market space.
Biogen
BIIB
Mkt Cap32.28B
Biogen Inc. specializes in therapies for neurological diseases, aligning closely with NTI's focus on neurotherapeutic products.
Ionis Pharmaceuticals
IONS
Mkt Cap10.15B
Ionis Pharmaceuticals, Inc. develops RNA-targeted therapies, including treatments for neurological diseases, competing with NTI's research and products.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly and Company has a strong portfolio in neurodegenerative treatments, making it a direct competitor in the neurological sector.
Novartis
NVS
Mkt Cap292.35B
Novartis AG offers several products for neurological conditions, competing in the same therapeutic area as NTI.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. has a diversified portfolio that includes treatments for neurological disorders, positioning it as a competitor to NTI.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG develops various neurology-focused therapies, directly competing with NTI's product range.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals Incorporated works on advanced treatments for several diseases, including neurological disorders, competing with NTI.

About

Neurotech International Limited (NTI.AX), along with its subsidiaries, is an Australian firm dedicated to the research, development, and manufacture of innovative medical devices and solutions. The company's primary focus lies in advancing and commercializing its Mente platform, a technological system designed to monitor and facilitate home-based therapies. This includes its Mente Autism product, specifically aimed at the diagnosis and treatment of autism spectrum disorder. Additionally, Neurotech actively undertakes various medical research projects and engineers new technological instruments. The company was established in 2016 and maintains its headquarters in Nedlands, Australia.
Show more...
CEO
Anthony Filippis
Employees
18
Country
Australia

Listings

AU
AU
NTI.AU

0 Comments

Share your thoughts

FAQ

What is NEUROTECH INTL LTD ORD stock price today?▼
The current price of NTILF is $0.00 USD — it has decreased by -0% in the past 24 hours. Watch NEUROTECH INTL LTD ORD stock price performance more closely on the chart.
What is NEUROTECH INTL LTD ORD stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange NEUROTECH INTL LTD ORD stocks are traded under the ticker NTILF.
What is NEUROTECH INTL LTD ORD revenue for the last year?▼
NEUROTECH INTL LTD ORD revenue for the last year amounts to 0 USD.
What is NEUROTECH INTL LTD ORD net income for the last year?▼
NTILF net income for the last year is -13.65M USD.
How many employees does NEUROTECH INTL LTD ORD have?▼
As of September 06, 2026, the company has 18 employees.
In which sector is NEUROTECH INTL LTD ORD located?▼
NEUROTECH INTL LTD ORD operates in the Health & Wellness sector.
When did NEUROTECH INTL LTD ORD complete a stock split?▼
NEUROTECH INTL LTD ORD has not had any recent stock splits.
Where is NEUROTECH INTL LTD ORD headquartered?▼
NEUROTECH INTL LTD ORD is headquartered in Melbourne, Australia.